Yang Shi Selected Research

RNA-Induced Silencing Complex

1/2018	LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
12/2011	Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Shi Research Topics

Disease

106	Neoplasms (Cancer) 05/2022 - 05/2003
19	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 09/2003
13	Inflammation (Inflammations) 07/2022 - 09/2007
13	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
11	Infections 02/2022 - 09/2003
11	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2004
11	Hypoxia (Hypoxemia) 06/2019 - 07/2002
9	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2004
9	Myocardial Infarction 01/2020 - 01/2008
8	Tauopathies 01/2022 - 01/2017
8	Carcinogenesis 01/2021 - 04/2003
7	Down Syndrome (Down's Syndrome) 01/2021 - 01/2016
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 05/2004
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 10/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 05/2003
6	Fibrosis (Cirrhosis) 10/2022 - 04/2016
6	Heart Failure 01/2020 - 11/2016
6	Intellectual Disability (Idiocy) 10/2017 - 01/2011
6	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 08/2010
6	Ischemia 01/2013 - 05/2004
5	Atherosclerosis 02/2022 - 01/2012
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2016
5	Leukemia 10/2021 - 06/2004
5	Carcinoma (Carcinomatosis) 01/2021 - 09/2003
5	Lung Neoplasms (Lung Cancer) 12/2020 - 01/2012
5	Hypertension (High Blood Pressure) 11/2016 - 01/2012
5	Pulmonary Hypertension 01/2013 - 07/2003
4	Hyperthermia 01/2022 - 03/2014
4	Hematologic Neoplasms (Hematological Malignancy) 03/2021 - 05/2003
4	Disease Progression 01/2021 - 07/2014
4	Lung Injury 01/2021 - 04/2004
4	Infarction (Infarctions) 01/2017 - 11/2007
3	Ischemic Stroke 07/2022 - 01/2018
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2010
3	Wounds and Injuries (Trauma) 08/2021 - 01/2017
3	Neuroinflammatory Diseases 01/2021 - 01/2017
3	Liver Neoplasms (Liver Cancer) 07/2020 - 01/2015
3	Hyperlipidemias (Hyperlipidemia) 08/2019 - 01/2014
3	Hemorrhage 06/2019 - 12/2012

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 08/2021 - 09/2003
25	Pharmaceutical PreparationsIBA 01/2022 - 05/2006
13	MicellesIBA 01/2022 - 06/2013
12	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2011
12	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2016
11	Apolipoproteins E (ApoE)IBA 02/2022 - 12/2016
11	Histones (Histone)IBA 01/2022 - 03/2007
9	EnzymesIBA 01/2022 - 10/2003
9	Biological ProductsIBA 10/2021 - 07/2004
8	LipidsIBA 02/2022 - 09/2010
8	Long Noncoding RNAIBA 01/2022 - 08/2014
8	Messenger RNA (mRNA)IBA 01/2022 - 11/2004
7	CytokinesIBA 12/2021 - 05/2016
7	ChromatinIBA 01/2021 - 02/2010
7	Peptides (Polypeptides)IBA 01/2020 - 01/2008
7	sapropterin (tetrahydrobiopterin)FDA Link 09/2017 - 04/2005
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2003
6	LigandsIBA 06/2021 - 09/2003
6	Cell Adhesion MoleculesIBA 01/2021 - 01/2016
6	Vitamin D FDA LinkGeneric 01/2018 - 01/2014
6	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2017 - 08/2002
5	Lysine (L-Lysine)FDA Link 05/2022 - 03/2007
5	AntigensIBA 01/2022 - 08/2010
5	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2003
5	ApolipoproteinsIBA 01/2022 - 12/2018
5	VaccinesIBA 11/2021 - 01/2006
5	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2011
5	Small Interfering RNA (siRNA)IBA 11/2020 - 09/2003
5	CurcuminIBA 01/2018 - 07/2002
5	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 09/2017 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 02/2014
4	MetalsIBA 03/2022 - 09/2018
4	CollagenIBA 02/2022 - 09/2010
4	ParaffinIBA 01/2022 - 08/2014
4	InterferonsIBA 01/2022 - 05/2006
4	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2020
4	Histone DemethylasesIBA 01/2021 - 03/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2020 - 06/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 03/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2013
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2017 - 04/2005
4	AfatinibIBA 06/2015 - 02/2014
4	sepiapterinIBA 01/2013 - 03/2010
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2011 - 08/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2010 - 08/2002
4	ProteomeIBA 01/2008 - 11/2004
3	AlbuminsIBA 01/2022 - 07/2020
3	Apolipoprotein E4IBA 01/2022 - 01/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
3	PolymersIBA 06/2020 - 03/2014
3	HydrogelsIBA 01/2020 - 10/2017
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2005

Therapy/Procedure

41	Therapeutics 04/2022 - 01/2003
11	Immunotherapy 04/2022 - 01/2018
8	Drug Therapy (Chemotherapy) 01/2022 - 07/2014
4	Radiotherapy 03/2021 - 01/2017
4	Segmental Mastectomy (Lumpectomy) 03/2021 - 01/2019
3	Stents 10/2022 - 07/2015
3	Microspheres (Microsphere) 11/2020 - 04/2005